Åsa Gustafsson‐Jernberg

Targeted monitoring of patients at high risk of post‐transplant lymphoproliferative disease by quantitative Epstein–Barr virus polymerase chain reaction

Hamdy Omar, H Hägglund, Åsa Gustafsson‐Jernberg et al. · Transplant Infectious Disease · 2009 · 77 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Leukocyte Depleted, Unscreened Blood Products Give a Low Risk for CMV Infection and Disease in CMV Seronegative Allogeneic Stem Cell Transplant Recipients with Seronegative Stem Cell Donors

Per Ljungman, Kajsa Larsson, Gunilla Kumlien et al. · Scandinavian Journal of Infectious Diseases · 2002 · 61 citations

Life Sciences, Immunology, Infectious Diseases +17

Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults

Thomas Poiret, Lalit Rane, Mats Remberger et al. · BMC Immunology · 2014 · 14 citations · Full text

Life Sciences, Hematology, Immunology +13

Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning

Qin Li, Lalit Rane, Thomas Poiret et al. · Oncotarget · 2016 · 13 citations · Full text

Medicine, Hematology, Pathology +13